Both in Pharmaceuticals
Grace Therapeutics vs Impact BioMedical
Over the past year GRCE returned −41.8% and IBO returned −40.3%; their daily moves had a correlation of 0.02.
GRCE −41.8% IBO −40.3%Growth of $1, one year, split-adjusted
| Metric | GRCE | IBO |
|---|---|---|
| Price | $1.81 | $4.01 |
| Market cap | $38.1M | $34.3M |
| Today | −6.70% | +5.53% |
| 1 month | −12.6% | −24.6% |
| 6 months | −23.3% | −50.0% |
| Year to date | −47.7% | −37.1% |
| 1 year | −43.3% | −39.6% |
| Revenue growth (YoY) | — | −57.1% |
| Gross margin | — | −533.3% |
| Net margin | — | −23300.0% |
| P/E (TTM) | — | 43.4× |
| Price / sales | — | 978.9× |
| Net cash | $13.8M | $10.0K |
| Dividend yield | — | — |
| Volatility (60d) | 43.6% | 736.6% |
| Short % of float | 11.2% | 0.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).